Key insights
- The author argues that Alight, Inc. (ALIT) is undervalued due to a completed goodwill impairment cycle, forced institutional selling, and a sales execution failure. They highlight a significant contractual cash obligation disappearing in 2027 that is not reflected in consensus estimates, potentially boosting equity value. Upcoming earnings on May 6 are crucial for validating the execution turnaround. This could positively influence US equities by highlighting potential value opportunities.
Disclosure: Long ALIT. Not investment advice.
Alight administers benefits for 30 million employees across Fortune 500 companies. It generates $354M in annual operating cash flow. It trades at $0.62 — 3.7x EV/EBITDA.
The market is pricing a broken business. The debt documents and operating metrics say otherwise.
Three things drove the price here simultaneously: a $3.1B non-cash goodwill impairment that is now finished, mandate-driven institutional liquidations triggered mechanically when the stock crossed $1.00, and a genuine sales execution failure that gave the market a fundamental reason to agree with the price.
The accounting distortion ends in 2026. The forced selling is documented and largely exhausted. The execution question is what May 6 answers.
There is one item in the 2025 10-K on page 21 that does not appear to be reflected in consensus estimates. It involves a contractual cash obligation that changes materially in 2027. I have quantified the equity value impact in the full write-up.
Kill criteria, valuation scenarios, debt structure, 13F ownership transfer, and the full thesis: